Nirsevimab Library
This is a collection of current resources related to Nirsevimab.
Respiratory Syncytial Virus: The Urgent Need for Innovative Preventive Strategies
2024
· Sapienza Università di Roma
This editorial describes the challenges and urgent need for new ways to prevent respiratory syncytial virus (RSV) infections, especially in infants. RSV is a common …
Ask aRCie
Respiratory Syncytial Virus Bronchiolitis: Rapid Evidence Review
This article is about RSV bronchiolitis, a common lung infection in young children. It describes how RSV spreads through droplets and suggests basic precautions like …
Assessing the Burden of Respiratory Syncytial Virus-Related Bronchiolitis in Primary Care and at 15-Day and 6-Month Follow-Up Before Prophylaxis in France: A Test-Negative Study
This study looks at the impact of RSV-related bronchiolitis in young children in France before RSV prevention methods were used. It describes how many children …
Knowledge, Attitudes and Behaviours of a Sample of Italian Paediatricians Towards RSV and its Preventive Strategies: A Cross-Sectional Study
2024
· Instituto Di Ricerche Farmacologiche Mario Negri (IRCCS),
· Università Cattolica del Sacro Cuore,
· Università degli Studi di Firenze,
· Università degli studi di Napoli Federico II
This article presents findings from a study on Italian pediatricians' knowledge, attitudes, and behaviors regarding respiratory syncytial virus (RSV) and its preventive strategies. The study …
RSV Prevention Options for Infants and Older Adults: A Specific Expanding Competitive Arena
This article focuses on respiratory syncytial virus (RSV), a common virus that can be serious for infants and older adults. It describes new ways to …
An Evaluation of 2015-2019 United States Respiratory Syncytial Virus Hospitalizations as a Framework to Develop Potential Strategies for the Prevention of the Hospital Burden Among Infants
This article evaluates RSV hospitalizations in the U.S. from 2015 to 2019 to develop strategies for reducing hospital burdens among infants. It describes two prevention …
Estimated Impact of Nirsevimab on the Incidence of Respiratory Syncytial Virus Infections Requiring Hospital Admission in Children <1 Year, Weeks 40, 2023, to 8, 2024, Spain
2024
· Institute of Health Carlos III (ISCIII),
· CIBER of Epidemiology and Public Health (CIBERESP),
· Government of Catalonia,
· Comunidad de Madrid,
· Junta de Andalucia,
· Junta de Castillo y Leon
This article discusses the impact of administering nirsevimab to children in Spain to prevent respiratory syncytial virus (RSV) infections requiring hospitalization. Data from the sentinel …
New Monoclonal Antibody Prevents RSV in Infants and Toddlers
This article discusses the approval of the monoclonal antibody nirsevimab-alip (Beyfortus) to prevent respiratory syncytial virus (RSV) in high-risk neonates and infants up to 24 …
Preventative Therapies for Respiratory Syncytial Virus (RSV) in Children: Where Are We Now?
This article reviews the current landscape of preventative therapies for respiratory syncytial virus (RSV) in children, focusing on the prefusion F protein as a key …
Analysis of Beyfortus® (Nirsevimab) Immunization Campaign: Effectiveness, Biases, and ADE Risks in RSV Prevention
2024
This review article analyzes the Beyfortus® (Nirsevimab) Immunization Campaign's effectiveness in preventing RSV infections. Nirsevimab shows promise in reducing hospitalizations due to RSV with its …